SCHEMBL14725708

SCHEMBL14725708

c1ccc(-n2c3ccccc3c3c4c(-c5cccc6c5oc5ccccc56)cc5cc6c(cc(-c7cccc8c7oc7ccccc78)c7c6ccc6c7c7ccccc7n6-c6ccccc6)cc5c4ccc32)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 2/20 0.40
▸ ATM Q13315 2/20 0.36
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ PRKDC P78527 5/20 0.36
▸ PIK3CD O00329 1/20 0.35
▸ PIK3CB P42338 1/20 0.35
▸ ALDH1A1 P00352 4/20 0.34
▸ SMN1; SMN2 Q16637 4/20 0.34
▸ TSHR P16473 2/20 0.34
▸ HSD17B10 Q99714 2/20 0.34
▸ LMNA P02545 2/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ BRCA1 P38398 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ PPARG P37231 1/20 0.33
▸ RXFP1 Q9HBX9 1/20 0.33
▸ NR2E3 Q9Y5X4 1/20 0.33
▸ NCOR2 Q9Y618 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25147357 0.85 ALOX5 (0.43) ALOX5ATML3MBTL1KDM4EPRKDC
SCHEMBL21914266 0.84 ALOX5 (0.43) ALOX5ATML3MBTL1KDM4EPRKDC
SCHEMBL14733782 0.84 KDM4E (0.46) ALOX5ATML3MBTL1KDM4EPRKDC
SCHEMBL19359852 0.83 ALOX5 (0.50) ALOX5ATML3MBTL1KDM4EPRKDC
SCHEMBL18619194 0.83 ALOX5 (0.40) ALOX5ATML3MBTL1KDM4EPRKDC
SCHEMBL14725705 0.83 KDM4E (0.36) ALOX5ATML3MBTL1KDM4EALDH1A1
SCHEMBL14725733 0.83 KDM4E (0.36) ALOX5ATML3MBTL1KDM4EPRKDC
SCHEMBL24041327 0.82 KDM4E (0.45) ALOX5ATML3MBTL1KDM4EPRKDC
SCHEMBL21116896 0.82 ALOX5 (0.51) ALOX5ATML3MBTL1KDM4EPRKDC
SCHEMBL15759558 0.82 ALOX5 (0.48) ALOX5ATML3MBTL1KDM4EPRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9255084-B2 Heterocyclic compound and organic light-emitting device containing the same SAMSUNG DISPLAY CO., LTD. (KR) 2016-02-09 — — US disclosed
US-20130048955-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING THE SAME SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2013-02-28 — — US disclosed
US-20130048955-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING THE SAME SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2013-02-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130048955-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING THE SAME TRPC1, TRPC4, TRPC6 ALOX5 648/4885ATM 4059/4885L3MBTL1 1029/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback